drug price
-
News
AIFA: report on timing. An average of 429 days pass from the approval of a drug by the EMA to its marketing in Italy
Report on the timing of drug pricing and reimbursement procedures in the four-year period 2018-2021 AIFA - 13 April 2022 The Agency…
Leggi » -
News
“Horizon Scanning: scenario of incoming medicines”. AIFA publishes the 2022 Report
In Europe, during 2021, 79 new medicines were authorized, of which 61 contain new active substances (25…
Leggi » -
News
If it expires, don't throw it away. App to donate medicines
Every year in Italy alone, about eight billion tablets are thrown away in the trash, almost 30% of the 24 billion…
Leggi » -
News
Cry of alarm from drug wholesalers: unsustainable costs. Scaccabarozzi: risk of drug shortage
Wholesalers, alarm on the economic sustainability of pharmaceutical distribution Skyrocketing energy costs, fuel price increases and NHS remuneration at…
Leggi » -
News
AIFA-led European plan against drug shortages
A three-year plan to coordinate and harmonize existing national medicines shortage systems. It is the project of…
Leggi » -
News
Parliament approved the law on rare diseases and orphan drugs. However, Aifa suspends access to the Fund for the reimbursement of orphan drugs
The Parliament has just unanimously approved the law on rare diseases with a strong reference to orphan drugs, both for…
Leggi » -
First floor
Competition bill. Medicines
The text of the competition bill, which currently has 34 articles, will probably be revised and corrected. Objective of the bill in…
Leggi » -
News
Unequal health, more drugs are consumed in the south
The Italian Medicines Agency (Aifa) has published the first Atlas of social inequalities in the use of medicines, a report that…
Leggi » -
News
Pfizer Announces $1Bn $ Bond Issue to Refinance Vaccine Research
Pfizer Inc. (NYSE: PFE) announced on August 16 the price of a “sustainable” bond of $ 1,000,000,000 in principal…
Leggi » -
News
Big Pharma, after the boom in profits thanks to vaccines, calls for exemption from the global minimum tax: "We deserve it"
The Wall Street Journal reports on a massive lobbying action on Washington and Brussels initiated by pharmaceutical companies…
Leggi »